Fabrice Chouraqui
Patrimonio netto: 162 673 $ in data 30/09/2026
Patrimonio netto: 162 673 $ in data 30/09/2026
Dr. Fabrice Chouraqui is an Independent Member-Governors Board at Orano Med Manufacturing SAS. He is on the Board of Directors at Orano Med Manufacturing SAS. Dr. Chouraqui was previously employed as a Chief Executive Officer & Executive Director by Pharming Group NV, a President by Novartis Pharmaceuticals Corp., and a Chief Executive Officer & Director by Cellarity Inc. He received his graduate degree from Universite Paris Cite, an MBA from INSEAD and a doctorate degree from Universite Paris Cite.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
PHARMING GROUP NV 0,02% | 31/03/2026 | 161.425 ( 0,02% ) | 162 673 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| PHARMING GROUP N.V. | Amministratore Delegato | 29/09/2026 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Presidente | 01/01/2019 |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Amministratore Delegato | 12/05/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale